Strange how the MF piece doesn't show up under STKL quote; I read it yesterday via HAIN.
"Will 2014 Be the Turnaround Year for SunOpta" Key word: "Will"
"My foresight tells me TRC share price will be the same 12 months from now as it is right now..."
3/8/13 - 3/7/14 Total Return
VTSAX = Vanguard's Total Market Index Fund
Let's hope TRC has a similar return for the next twelve months, although today was not a good start.
You are efficient; it's been a week or so since your latest salvo of SPAM and then BOOM!
Within four minutes, you hit both boards (apparently your only territory--and what a lousy territory you were assigned! Nice market cap for ECOS)
pslabowski, it's all good and good fun; I hope you don't have me in the "resent it" camp.
I just wanted to add my 13 cents to the conversation.
pslabowski, who knows when, but sometime biotech will not be the favored sector. Perhaps some are taking advantage of the multi-year massive run and taking some off the table and rotating into an other sector or sectors. I sold some of my fund a month or so ago and by doing so, I'm not as uneasy holding the rest! Reading trends is a good idea; but I simply use chart of the NAV. Remember the days when FIDO had several funds that were priced hourly?
For perspective, I hold biotech only in my ROTH and after my sale, it represents approx. 6.0% of that account and just 1.5% of all my holdings. Approx. 30% is in Total Market Funds, since after years of investing, I have concluded that it's not easy to beat the market (some years I have and others I haven't--similar to IBB v FBIOX lol). Index funds are very tax efficient.
Again, I appreciate the fun that is derived from playing with numbers. I used to update an excel spreadsheet of my positions, presented in different ways, on a monthly basis. Now I do it quarterly. By doing this, I feel (and believe) I'm more in touch with the trends etc.
P.S. I hope those who are overweighted/heavily overweighted in biotech can sense when the lights may be dimming and are able to take huge profits. As I've aged, my tolerance for various risks such as holding such a concentrated position has declined; that said, IMO I'm quite the risk taker given I have 88% in equities and 12% in cash like positions and no bonds (down from the decades of being about 99% in equities).
I challenge readers of this board to do a quick survey with their friends or co-workers by asking them if they:
A. Know what kefir is
B. If they have ever heard of Lifeway
While it may be a good move to introduce new products, there has to be demand for them. I continue to be long because I believe there is potential for LWAY, but I sure wish the company would shift from 2nd gear to at least 3rd (more marketing and when I write "marketing" I mean beyond social media). IMO there are a lot of prospective LWAY kefir consumers, but they don't play with social media and as a result, most likely have never heard of kefir, let alone LWAY kefir.
Speaking of the new products...I hope they sell well. I love vegetables, but I can say with certainty that I won't be consuming Tomato, Cucumber or Beet kefir! I may sample the oat powder kefir and the "Perfect 12" which is targeted to those opposed to consuming a lot of sugar. (IMO LWAY's flagship kefir is way too SWEET!!!) That is IF I can find such a product (once it's released) in my area. There are several different fruit flavors of LWAY kefir, but where I shop (WFM and other outlets), I rarely see more than four different flavors (and it seems like it's always the same four). BioKefir? Nope. It was (past tense) sold at one of the two WFMs I frequent and I did buy it. No longer available. I asked the dude stocking dairy and he said this WFM discontinued "sales" of BioKefir simply because its sales were minimal. Odd given every Q management states sales increased due to its flagship kefir, BioKefir...
Time to bring in an effective marketing person to ramp up sales. Added benefit: Julie will have more time for her outside activities!
I say halt the annual .08 dividend and use the "savings" for the salary of the new experienced Marketing Officer; feel free to toss in some options as well.
Let's be real: no one benefits much from the paltry dividend, with the exception of the family.
Do what is best for ALL.
"The typical reader of the rag is a paycheck away from being on welfare and is not a high school graduate."
Did you have fun posting this nugget?
P.S. Don't let Barron's advertisers in on your "knowledge" of their "typical reader".
Cosmo Kramer or Jim Cramer???
"Theformer owner will be the one laughing at all these big bankers when he gets the company back for pennies."
Of course the bankers already made coin with the IPO and if, and it's a BIG IF, FWM was privatized, I'd say the "big bankers" would also make many bucks advising on such a transaction.
You wouldn't happen to be a politician, would you?
How about a wannabe fiction writer?
While I can somewhat appreciate the fun aspect of trying to model FBIOX and thereby attempt to calculate its close, I wonder when you may tire of this exercise. From past experience, I do know that it is more fun to do calculations when the market, or a particular sector, is UP LOL. IBB is a good proxy for the biotech sector; if IBB is up, most biotech funds will be up and vice a versa. I don't understand the rush to determine FBIOX's close. Generally speaking, investing in a fund is a long term proposition; I do look at individual equity prices somewhat frequently, but my funds let alone a fund's individual holdings? Not so much; I do monitor my funds' performance and particularly against the proper benchmark. While some on this board have almost deified Kaul, over the last 5 years, 2 years and one year, FBIOX has slighlty underperformed v IBB, but the results have been very close to one another. Same can be said for the past six months. FBIOX has outperformed IBB by a decent measure over the last three months, but in fund investing terms, three months is just a blip. The nice short term appreciation FBIOX has delivered V IBB is impressive given the underperformance of GILD, its largest holding by far--approx. 16% of assets (I presume GILD's quadrupaling accounts for is HUGE weighting). So yes, some credit should be given to Kaul, but keeping things in pespective by looking at long term results, FBIOX has pretty much mirrored IBB which is based on an index.
Again, playing with numbers can be fun/entertaining, but I'm not clear what the actual purpose is in this case.
I see you are still up to your "mature" games.
How you have not become bored by pretty much posting the same silliness, but on different boards (you move on when one of your targets has greatly appreciated proving said silliness), is beyond me.
Try actually investing; it's fun to make some money!!!